Denali Therapeutics Announces Positive Clinical Results With Its Lead RIPK1 Inhibitor Molecule Pharmaceutical Investing
PreveCeutical Converts Acidic Phytocannabinoids to Neutral Form and Doubles Contents of Fingerprinted Cannabis Extract Library Cannabis Investing News
GlycoMimetics Enrolls First Patient in Global Phase 3 Clinical Trial of Uproleselan in Relapsed/Refractory Acute Myeloid Leukemia Life Science Investing
TRACON Pharmaceuticals Presents Data from Phase 2 Trial of TRC102 and Temodar Pharmaceutical Investing
Atara Biotherapeutics Announces Publication of Phase 1 Study Demonstrating Clinical Improvement Pharmaceutical Investing
Isodiol International Inc. Announces Update to Previously Announced Convertible Debenture Offering Cannabis Investing News
BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium Biotech Investing
PreveCeutical Confirms Encouraging Results from Sol-gel Applicator Trials for Achieving Direct Nose-to-Brain Delivery in an Adult Human Nasal Cast Cannabis Investing News
